Gregg Williams Purchases 3,968,253 Shares of Vivani Medical, Inc. (NASDAQ:VANI) Stock

Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams purchased 3,968,253 shares of the company’s stock in a transaction dated Friday, November 8th. The stock was purchased at an average price of $1.26 per share, with a total value of $4,999,998.78. Following the transaction, the director now owns 4,695,861 shares of the company’s stock, valued at approximately $5,916,784.86. This represents a 500.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Vivani Medical Stock Performance

Shares of Vivani Medical stock opened at $1.25 on Wednesday. Vivani Medical, Inc. has a 1 year low of $0.84 and a 1 year high of $7.80. The business has a 50 day moving average price of $1.22 and a 200 day moving average price of $1.36.

Vivani Medical (NASDAQ:VANI) last issued its quarterly earnings data on Tuesday, August 13th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.02.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright assumed coverage on shares of Vivani Medical in a report on Thursday, November 7th. They set a “buy” rating and a $3.00 target price for the company.

About Vivani Medical

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.